Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OXALIPLATIN Cause Suspected product quality issue? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Suspected product quality issue have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.0% of all adverse event reports for OXALIPLATIN.

11
Reports of Suspected product quality issue with OXALIPLATIN
0.0%
of all OXALIPLATIN reports
1
Deaths
3
Hospitalizations

How Dangerous Is Suspected product quality issue From OXALIPLATIN?

Of the 11 reports, 1 (9.1%) resulted in death, 3 (27.3%) required hospitalization, and 2 (18.2%) were considered life-threatening.

Is Suspected product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does OXALIPLATIN Cause?

Diarrhoea (4,963) Nausea (4,250) Neuropathy peripheral (3,662) Off label use (3,603) Neutropenia (3,391) Vomiting (3,383) Disease progression (3,370) Thrombocytopenia (2,886) Dyspnoea (2,779) Pyrexia (2,269)

What Other Drugs Cause Suspected product quality issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (64) LEVOTHYROXINE (37) HUMAN IMMUNOGLOBULIN G (32) ESTRADIOL (30) ONABOTULINUMTOXINA (30) SODIUM (30) CLONAZEPAM (29) AFLIBERCEPT (27) INSULIN GLARGINE (27) IOPROMIDE (25)

Which OXALIPLATIN Alternatives Have Lower Suspected product quality issue Risk?

OXALIPLATIN vs OXAPROZIN OXALIPLATIN vs OXAZEPAM OXALIPLATIN vs OXCARBAZEPINE OXALIPLATIN vs OXITRIPTAN OXALIPLATIN vs OXOMEMAZINE

Related Pages

OXALIPLATIN Full Profile All Suspected product quality issue Reports All Drugs Causing Suspected product quality issue OXALIPLATIN Demographics